Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price: 1,698.80
Bid: 1,698.60
Ask: 1,699.00
Change: 0.00 (0.00%)
Spread: 0.40 (0.02%)
Open: 1,692.60
High: 1,699.60
Low: 1,687.80
Yest. Close: 1,676.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

US Food & Drug Administration Accepts GSK's Application For Zejula

Mon, 24th Jun 2019 12:25

(Alliance News) - GlaxoSmithKline PLC on Monday said Tesaro, its oncology-focused business, submitted a supplemental new drug application to the US Food & Drug Administration for Zejula.

The drugmaker said the application was granted priority review and has an action date of October 24.

"We know Zejula plays an important role in helping women with ovarian cancer whose disease has progressed despite initial therapy," said Hal Barron, chief scientific officer & president at GSK's Research & Development unit.

"Our hope is that over time, our ongoing clinical trials will demonstrate that this medicine can benefit even more patients," added Barron.

GSK shares were trading 0.2% higher on Monday at 1,579.00 pence each in London.

More News

GlaxoSmithKline's Dreamm-2 Multiple Myeloma Trial Results Encouraging

(Alliance News) - GlaxoSmithKline PLC on Friday reported positive headline results from its Dreamm-2 study of belantamab mafodotin in multiple myeloma.The study, which involved 196 patients

23 Aug 19 07:46

GlaxoSmithKline reveals positive results from belantamab mafodotin trial

(Sharecast News) - GlaxoSmithKline announced positive headline results from the pivotal 'DREAMM-2' open-label, randomised study of two doses of belantamab mafodotin on Friday.

23 Aug 19 07:29

Glaxo's ViiV Reports Positive Study Results Of HIV-Treatment Regimen

(Alliance News) - GlaxoSmithKline PLC on Thursday said ViiV Healthcare reported positive headline results from its global phase III ATLAS-2M study.ViiV Healthcare is a specialist HIV owned

22 Aug 19 08:20

GlaxoSmithKline upbeat on latest test results from ViiV Healthcare

(Sharecast News) - GlaxoSmithKline reported on Thursday that its specialist HIV company ViiV Healthcare had announced positive headline results from its phase 3 'ATLAS-2M' study of the investigational, long-acting, injectable, two-drug regimen (2DR) of its cabotegravir and Janssen's rilpivirine for the treatment of HIV.

22 Aug 19 07:29

Glaxo Submits Japanese Application For Daprodustat Anaemia Drug

(Alliance News) - GlaxoSmithKline PLC on Wednesday said it has submitted a new drug application in Japan for anaemia drug daprodustat.The application was submitted to the Japanese Ministry

21 Aug 19 08:38

GlaxoSmithKline seeking marketing approval for 'daprodustat' in Japan

(Sharecast News) - GlaxoSmithKline announced the submission of a Japanese New Drug Application (JNDA) to the Ministry of Health, Labour and Welfare on Wednesday, seeking marketing approval for 'daprodustat'.

21 Aug 19 08:07

WINNERS & LOSERS SUMMARY: Plus500 Up On Share Buyback, New Customers

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------TUI, up

13 Aug 19 10:09

LONDON MARKET OPEN: TUI And Plus500 Both Rise Despite Profit Falls

(Alliance News) - Stock prices in London opened lower on Tuesday as concerns about the US-China trade war, protests in Hong Kong, and fears of a global economic slowdown continue to sap sentiment.

13 Aug 19 08:43

Glaxo US Pharma Head To Leave Role, Poaches Merck KGaA Oncology Head

(Alliance News) - GlaxoSmithKline PLC said on Monday that the head of its US pharmaceuticals division Jack Bailey will step down at the end of the year and will be replaced by Merck KGaA's the

12 Aug 19 17:00

MidaTech Pharma Appoints Frederic Duchesne As Non-Executive Director

(Alliance News) - Midatech Pharma PLC said Wednesday that Frederic Duchesne had been appointed as a non-executive director, effective immediately.Duchesne was chief executive of the of May.

31 Jul 19 15:54

GlaxoSmithKline Notes Positive Tango And Gemini HIV Study Results

(Alliance News) - GlaxoSmithKline PLC on Wednesday noted positive results from the Gemini and Tango phase three studies of a dolutegravir plus lamivudine in HIV patients.The results were by

24 Jul 19 17:20

TOP NEWS: GlaxoSmithKline Profit Up In First Half; Guidance Improved

(Alliance News) - GlaxoSmithKline PLC on Wednesday said its profit rose almost 50% in the first half of the year due to strong performances from its Vaccines and Consumer Healthcare also upgraded

24 Jul 19 12:35

LONDON MARKET MIDDAY: Miners Press FTSE Deeper Into Red On Vale News

(Alliance News) - Miners put the FTSE 100 under pressure on Wednesday while the FTSE 250 battled to stay in the green in the face of a 24% slump for luxury car maker Aston large-cap FTSE a

24 Jul 19 11:53

TOP NEWS: GlaxoSmithKline Hires Ex-Astra Finance Boss Symonds As Chair

(Alliance News) - GlaxoSmithKline PLC said Wednesday former AstraZeneca PLC finance chief Jonathan Symonds will replace outgoing Chair Philip Hampton at the FTSE 100-listed drugmaker from the of a

24 Jul 19 10:34

GlaxoSmithKline's ViiV Healthcare Gets Positive Fostemsavir Results

(Alliance News) - GlaxoSmithKline PLC on Monday said its ViiV Healthcare has seen positive results from the phase three Brighte study of investigational fostemsavir in heavily adults with is HIV a

22 Jul 19 17:19

Login to your account

Don't have an account? Click here to register.